Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Faeh

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|June 5, 2024
Risks and benefits of nonsugar sweeteners: conflicting evidence between observational studies and randomized controlled trialsDavid Faeh
Obesity (Silver Spring, Md.)|September 26, 2009
Increase in the prevalence of obesity in Switzerland 1982-2007: birth cohort analysis puts recent slowdown into perspectiveDavid Faeh, Matthias Bopp
BMC Public Health|October 2, 2008
End-digits preference for self-reported height depends on languageMatthias Bopp, David Faeh
BMC Medicine|July 20, 2013
Should we go nuts about nuts?Sabine Rohrmann, David Faeh
BMC Public Health|September 23, 2010
Educational inequalities in mortality and associated risk factors: German--versus French-speaking SwitzerlandDavid Faeh, Matthias Bopp,
Cardiovascular Diabetology|January 29, 2013
Blood glucose may be an alternative to cholesterol in CVD risk prediction chartsJulia Braun, Matthias Bopp, David Faeh
Swiss Medical Weekly|January 17, 2007
Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?David Faeh, Arnaud Chiolero, Fred Paccaud
Circulation|July 29, 2009
Lower mortality from coronary heart disease and stroke at higher altitudes in SwitzerlandDavid Faeh, Felix Gutzwiller, Matthias Bopp, et al.
Diabetes Care|September 20, 2011
Routine data sources challenge international diabetes Federation extrapolations of national diabetes prevalence in SwitzerlandMatthias Bopp, Ueli Zellweger, David Faeh
European Journal of Epidemiology|July 18, 2013
Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction chartsDavid Faeh, Sabine Rohrmann, Julia Braun
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Current Opinion in Clinical Nutrition and Metabolic Care|June 5, 2024
Risks and benefits of nonsugar sweeteners: conflicting evidence between observational studies and randomized controlled trialsDavid Faeh
Obesity (Silver Spring, Md.)|September 26, 2009
Increase in the prevalence of obesity in Switzerland 1982-2007: birth cohort analysis puts recent slowdown into perspectiveDavid Faeh, Matthias Bopp
BMC Public Health|October 2, 2008
End-digits preference for self-reported height depends on languageMatthias Bopp, David Faeh
BMC Medicine|July 20, 2013
Should we go nuts about nuts?Sabine Rohrmann, David Faeh
BMC Public Health|September 23, 2010
Educational inequalities in mortality and associated risk factors: German--versus French-speaking SwitzerlandDavid Faeh, Matthias Bopp,
Cardiovascular Diabetology|January 29, 2013
Blood glucose may be an alternative to cholesterol in CVD risk prediction chartsJulia Braun, Matthias Bopp, David Faeh
Swiss Medical Weekly|January 17, 2007
Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?David Faeh, Arnaud Chiolero, Fred Paccaud
Circulation|July 29, 2009
Lower mortality from coronary heart disease and stroke at higher altitudes in SwitzerlandDavid Faeh, Felix Gutzwiller, Matthias Bopp, et al.
Diabetes Care|September 20, 2011
Routine data sources challenge international diabetes Federation extrapolations of national diabetes prevalence in SwitzerlandMatthias Bopp, Ueli Zellweger, David Faeh
European Journal of Epidemiology|July 18, 2013
Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction chartsDavid Faeh, Sabine Rohrmann, Julia Braun
Pageof 7